Global Small Molecule Drug 3D Printing 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI05240965

Publication Date:

June 3, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Small Molecule Drug 3D Printing refers to a technology that involves the use of 3D printing techniques to fabricate pharmaceuticals containing small molecule drugs. Unlike traditional manufacturing methods where drugs are typically produced in bulk as tablets or capsules with uniform dosages, 3D printing allows for the creation of personalized medicine and complex dosage forms on a patient-by-patient basis.
The global Small Molecule Drug 3D Printing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淪mall Molecule Drug 3D Printing Industry Forecast鈥� looks at past sales and reviews total world Small Molecule Drug 3D Printing sales in 2022, providing a comprehensive analysis by region and market sector of projected Small Molecule Drug 3D Printing sales for 2023 through 2029. With Small Molecule Drug 3D Printing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Drug 3D Printing industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Drug 3D Printing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Drug 3D Printing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Small Molecule Drug 3D Printing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Drug 3D Printing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Drug 3D Printing.
United States market for Small Molecule Drug 3D Printing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Small Molecule Drug 3D Printing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Small Molecule Drug 3D Printing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Small Molecule Drug 3D Printing players cover Aprecia, FabRx, Multiply Labs, Merck KGaA, Triastek, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Drug 3D Printing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Material Extrusion
Binder Jetting
Powder Bed Fusion
Other
Segmentation by Application:
Large-scale Production
Personalized Pharmaceutical
Concept Research and Technology Development
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Material Extrusion
Binder Jetting
Powder Bed Fusion
Other
Segmentation by Application:
Large-scale Production
Personalized Pharmaceutical
Concept Research and Technology Development
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aprecia
FabRx
Multiply Labs
Merck KGaA
Triastek
MSD
AstraZeneca
TNO
Multiply Labs
DiHeSys

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Small Molecule Drug 3D Printing 麻豆原创 Size 2019-2030
2.1.2 Small Molecule Drug 3D Printing 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Small Molecule Drug 3D Printing by Country/Region, 2019, 2023 & 2030
2.2 Small Molecule Drug 3D Printing Segment by Type
2.2.1 Material Extrusion
2.2.2 Binder Jetting
2.2.3 Powder Bed Fusion
2.2.4 Other
2.3 Small Molecule Drug 3D Printing 麻豆原创 Size by Type
2.3.1 Small Molecule Drug 3D Printing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Small Molecule Drug 3D Printing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Small Molecule Drug 3D Printing Segment by Application
2.4.1 Large-scale Production
2.4.2 Personalized Pharmaceutical
2.4.3 Concept Research and Technology Development
2.5 Small Molecule Drug 3D Printing 麻豆原创 Size by Application
2.5.1 Small Molecule Drug 3D Printing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Small Molecule Drug 3D Printing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Small Molecule Drug 3D Printing 麻豆原创 Size by Player
3.1 Small Molecule Drug 3D Printing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Small Molecule Drug 3D Printing Revenue by Player (2019-2024)
3.1.2 Global Small Molecule Drug 3D Printing Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Small Molecule Drug 3D Printing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule Drug 3D Printing by Region
4.1 Small Molecule Drug 3D Printing 麻豆原创 Size by Region (2019-2024)
4.2 Global Small Molecule Drug 3D Printing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Small Molecule Drug 3D Printing 麻豆原创 Size Growth (2019-2024)
4.4 APAC Small Molecule Drug 3D Printing 麻豆原创 Size Growth (2019-2024)
4.5 Europe Small Molecule Drug 3D Printing 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Small Molecule Drug 3D Printing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Small Molecule Drug 3D Printing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Small Molecule Drug 3D Printing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Small Molecule Drug 3D Printing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Drug 3D Printing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Small Molecule Drug 3D Printing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Small Molecule Drug 3D Printing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule Drug 3D Printing 麻豆原创 Size by Country (2019-2024)
7.2 Europe Small Molecule Drug 3D Printing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Small Molecule Drug 3D Printing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Drug 3D Printing by Region (2019-2024)
8.2 Middle East & Africa Small Molecule Drug 3D Printing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Small Molecule Drug 3D Printing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Small Molecule Drug 3D Printing 麻豆原创 Forecast
10.1 Global Small Molecule Drug 3D Printing Forecast by Region (2025-2030)
10.1.1 Global Small Molecule Drug 3D Printing Forecast by Region (2025-2030)
10.1.2 Americas Small Molecule Drug 3D Printing Forecast
10.1.3 APAC Small Molecule Drug 3D Printing Forecast
10.1.4 Europe Small Molecule Drug 3D Printing Forecast
10.1.5 Middle East & Africa Small Molecule Drug 3D Printing Forecast
10.2 Americas Small Molecule Drug 3D Printing Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.2.2 Canada 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.2.3 Mexico 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.2.4 Brazil 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.3 APAC Small Molecule Drug 3D Printing Forecast by Region (2025-2030)
10.3.1 China Small Molecule Drug 3D Printing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.3.3 Korea 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.3.4 Southeast Asia 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.3.5 India 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.3.6 Australia 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.4 Europe Small Molecule Drug 3D Printing Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.4.2 France 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.4.3 UK 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.4.4 Italy 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.4.5 Russia 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.5 Middle East & Africa Small Molecule Drug 3D Printing Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.5.2 South Africa 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.5.3 Israel 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.5.4 Turkey 麻豆原创 Small Molecule Drug 3D Printing Forecast
10.6 Global Small Molecule Drug 3D Printing Forecast by Type (2025-2030)
10.7 Global Small Molecule Drug 3D Printing Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Small Molecule Drug 3D Printing Forecast
11 Key Players Analysis
11.1 Aprecia
11.1.1 Aprecia Company Information
11.1.2 Aprecia Small Molecule Drug 3D Printing Product Offered
11.1.3 Aprecia Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Aprecia Main Business Overview
11.1.5 Aprecia Latest Developments
11.2 FabRx
11.2.1 FabRx Company Information
11.2.2 FabRx Small Molecule Drug 3D Printing Product Offered
11.2.3 FabRx Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 FabRx Main Business Overview
11.2.5 FabRx Latest Developments
11.3 Multiply Labs
11.3.1 Multiply Labs Company Information
11.3.2 Multiply Labs Small Molecule Drug 3D Printing Product Offered
11.3.3 Multiply Labs Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Multiply Labs Main Business Overview
11.3.5 Multiply Labs Latest Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Information
11.4.2 Merck KGaA Small Molecule Drug 3D Printing Product Offered
11.4.3 Merck KGaA Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Merck KGaA Main Business Overview
11.4.5 Merck KGaA Latest Developments
11.5 Triastek
11.5.1 Triastek Company Information
11.5.2 Triastek Small Molecule Drug 3D Printing Product Offered
11.5.3 Triastek Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Triastek Main Business Overview
11.5.5 Triastek Latest Developments
11.6 MSD
11.6.1 MSD Company Information
11.6.2 MSD Small Molecule Drug 3D Printing Product Offered
11.6.3 MSD Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 MSD Main Business Overview
11.6.5 MSD Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Small Molecule Drug 3D Printing Product Offered
11.7.3 AstraZeneca Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 TNO
11.8.1 TNO Company Information
11.8.2 TNO Small Molecule Drug 3D Printing Product Offered
11.8.3 TNO Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 TNO Main Business Overview
11.8.5 TNO Latest Developments
11.9 Multiply Labs
11.9.1 Multiply Labs Company Information
11.9.2 Multiply Labs Small Molecule Drug 3D Printing Product Offered
11.9.3 Multiply Labs Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Multiply Labs Main Business Overview
11.9.5 Multiply Labs Latest Developments
11.10 DiHeSys
11.10.1 DiHeSys Company Information
11.10.2 DiHeSys Small Molecule Drug 3D Printing Product Offered
11.10.3 DiHeSys Small Molecule Drug 3D Printing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 DiHeSys Main Business Overview
11.10.5 DiHeSys Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.